Report Detail

Request for Sample of this report

Pharma & Healthcare Global Mesylate Safinamide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4707740
    • |
  • 09 June, 2026
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Mesylate Safinamide market size was valued at US$ 576 million in 2025 and is forecast to a readjusted size of US$ 1455 million by 2032 with a CAGR of 15.0% during review period.
In 2025, global safinamide mesylate tablet production reached approximately 321,700 units.Safinamide is a medication used to treat Parkinson's disease, primarily working by inhibiting monoamine oxidase B (MAO-B) and enhancing dopamine release. It helps regulate the dopamine system in the brain, alleviating motor symptoms in Parkinson's disease patients, such as tremors, rigidity, and bradykinesia. Safinamide is often used in combination with levodopa to enhance treatment efficacy, particularly when the effects of levodopa diminish. The medication is typically available in oral tablet form, and patients use it according to their doctor's guidance. During treatment, safinamide can significantly improve the patient's quality of life and reduce symptom fluctuations.
Safinamide holds an important position in the global Parkinson's disease treatment market, especially in improving motor symptoms in Parkinson's disease patients. With the aging population increasing, the number of Parkinson's disease patients globally continues to rise, providing a broad market demand for Safinamide. This drug works by inhibiting monoamine oxidase B (MAO-B) and enhancing dopamine release, alleviating symptoms in Parkinson's disease patients. When used in combination with levodopa, it significantly improves treatment outcomes and enhances the quality of life for patients. The market prospects for Safinamide are driven by several factors. Firstly, with the increase in early diagnosis of Parkinson's disease, the demand for effective medications among patients is growing. Secondly, Safinamide has strong competitiveness in the market, particularly among levodopa-resistant patient populations, where its use is gradually being recognized. However, there is still competition from other drugs such as dopamine agonists and anticholinergic medications, which results in a competitive market environment.
This report is a detailed and comprehensive analysis for global Mesylate Safinamide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mesylate Safinamide market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mesylate Safinamide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mesylate Safinamide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mesylate Safinamide market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mesylate Safinamide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mesylate Safinamide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zambon S.p.A., Polpharma, Biophore India Pharmaceuticals Pvt Ltd, LGM Pharma, Metrochem API Private Limited, Cohance Lifesciences, Zhejiang Hengkang Pharmaceutical, HRV Pharma, Honour Lab Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mesylate Safinamide market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hospitals
Retail
Online
Market segment by Combination Therapy
Safinamide Mesylate in combination with Dopamine Receptor Agonists
Safinamide Mesylate in combination with Levodopa
Market segment by Dosage Form
Oral
Injectable
Market segment by Manufacturing Technology
Innovator
Generic
Market segment by Application
Used in combination with Levodopa
Treatment of Levodopa-resistant Parkinson's Disease
Others
Major players covered
Zambon S.p.A.
Polpharma
Biophore India Pharmaceuticals Pvt Ltd
LGM Pharma
Metrochem API Private Limited
Cohance Lifesciences
Zhejiang Hengkang Pharmaceutical
HRV Pharma
Honour Lab Limited
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mesylate Safinamide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mesylate Safinamide, with price, sales quantity, revenue, and global market share of Mesylate Safinamide from 2021 to 2026.
Chapter 3, the Mesylate Safinamide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mesylate Safinamide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Mesylate Safinamide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mesylate Safinamide.
Chapter 14 and 15, to describe Mesylate Safinamide sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Mesylate Safinamide Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Hospitals
    • 1.3.3 Retail
    • 1.3.4 Online
  • 1.4 Market Analysis by Combination Therapy
    • 1.4.1 Overview: Global Mesylate Safinamide Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
    • 1.4.2 Safinamide Mesylate in combination with Dopamine Receptor Agonists
    • 1.4.3 Safinamide Mesylate in combination with Levodopa
  • 1.5 Market Analysis by Dosage Form
    • 1.5.1 Overview: Global Mesylate Safinamide Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
    • 1.5.2 Oral
    • 1.5.3 Injectable
  • 1.6 Market Analysis by Manufacturing Technology
    • 1.6.1 Overview: Global Mesylate Safinamide Consumption Value by Manufacturing Technology: 2021 Versus 2025 Versus 2032
    • 1.6.2 Innovator
    • 1.6.3 Generic
  • 1.7 Market Analysis by Application
    • 1.7.1 Overview: Global Mesylate Safinamide Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 Used in combination with Levodopa
    • 1.7.3 Treatment of Levodopa-resistant Parkinson's Disease
    • 1.7.4 Others
  • 1.8 Global Mesylate Safinamide Market Size & Forecast
    • 1.8.1 Global Mesylate Safinamide Consumption Value (2021 & 2025 & 2032)
    • 1.8.2 Global Mesylate Safinamide Sales Quantity (2021-2032)
    • 1.8.3 Global Mesylate Safinamide Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Zambon S.p.A.
    • 2.1.1 Zambon S.p.A. Details
    • 2.1.2 Zambon S.p.A. Major Business
    • 2.1.3 Zambon S.p.A. Mesylate Safinamide Product and Services
    • 2.1.4 Zambon S.p.A. Mesylate Safinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Zambon S.p.A. Recent Developments/Updates
  • 2.2 Polpharma
    • 2.2.1 Polpharma Details
    • 2.2.2 Polpharma Major Business
    • 2.2.3 Polpharma Mesylate Safinamide Product and Services
    • 2.2.4 Polpharma Mesylate Safinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Polpharma Recent Developments/Updates
  • 2.3 Biophore India Pharmaceuticals Pvt Ltd
    • 2.3.1 Biophore India Pharmaceuticals Pvt Ltd Details
    • 2.3.2 Biophore India Pharmaceuticals Pvt Ltd Major Business
    • 2.3.3 Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Product and Services
    • 2.3.4 Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Biophore India Pharmaceuticals Pvt Ltd Recent Developments/Updates
  • 2.4 LGM Pharma
    • 2.4.1 LGM Pharma Details
    • 2.4.2 LGM Pharma Major Business
    • 2.4.3 LGM Pharma Mesylate Safinamide Product and Services
    • 2.4.4 LGM Pharma Mesylate Safinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 LGM Pharma Recent Developments/Updates
  • 2.5 Metrochem API Private Limited
    • 2.5.1 Metrochem API Private Limited Details
    • 2.5.2 Metrochem API Private Limited Major Business
    • 2.5.3 Metrochem API Private Limited Mesylate Safinamide Product and Services
    • 2.5.4 Metrochem API Private Limited Mesylate Safinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Metrochem API Private Limited Recent Developments/Updates
  • 2.6 Cohance Lifesciences
    • 2.6.1 Cohance Lifesciences Details
    • 2.6.2 Cohance Lifesciences Major Business
    • 2.6.3 Cohance Lifesciences Mesylate Safinamide Product and Services
    • 2.6.4 Cohance Lifesciences Mesylate Safinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Cohance Lifesciences Recent Developments/Updates
  • 2.7 Zhejiang Hengkang Pharmaceutical
    • 2.7.1 Zhejiang Hengkang Pharmaceutical Details
    • 2.7.2 Zhejiang Hengkang Pharmaceutical Major Business
    • 2.7.3 Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Product and Services
    • 2.7.4 Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
  • 2.8 HRV Pharma
    • 2.8.1 HRV Pharma Details
    • 2.8.2 HRV Pharma Major Business
    • 2.8.3 HRV Pharma Mesylate Safinamide Product and Services
    • 2.8.4 HRV Pharma Mesylate Safinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 HRV Pharma Recent Developments/Updates
  • 2.9 Honour Lab Limited
    • 2.9.1 Honour Lab Limited Details
    • 2.9.2 Honour Lab Limited Major Business
    • 2.9.3 Honour Lab Limited Mesylate Safinamide Product and Services
    • 2.9.4 Honour Lab Limited Mesylate Safinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Honour Lab Limited Recent Developments/Updates

3 Competitive Environment: Mesylate Safinamide by Manufacturer

  • 3.1 Global Mesylate Safinamide Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Mesylate Safinamide Revenue by Manufacturer (2021-2026)
  • 3.3 Global Mesylate Safinamide Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Mesylate Safinamide by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Mesylate Safinamide Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Mesylate Safinamide Manufacturer Market Share in 2025
  • 3.5 Mesylate Safinamide Market: Overall Company Footprint Analysis
    • 3.5.1 Mesylate Safinamide Market: Region Footprint
    • 3.5.2 Mesylate Safinamide Market: Company Product Type Footprint
    • 3.5.3 Mesylate Safinamide Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Mesylate Safinamide Market Size by Region
    • 4.1.1 Global Mesylate Safinamide Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Mesylate Safinamide Consumption Value by Region (2021-2032)
    • 4.1.3 Global Mesylate Safinamide Average Price by Region (2021-2032)
  • 4.2 North America Mesylate Safinamide Consumption Value (2021-2032)
  • 4.3 Europe Mesylate Safinamide Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Mesylate Safinamide Consumption Value (2021-2032)
  • 4.5 South America Mesylate Safinamide Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Mesylate Safinamide Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Mesylate Safinamide Sales Quantity by Type (2021-2032)
  • 5.2 Global Mesylate Safinamide Consumption Value by Type (2021-2032)
  • 5.3 Global Mesylate Safinamide Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Mesylate Safinamide Sales Quantity by Application (2021-2032)
  • 6.2 Global Mesylate Safinamide Consumption Value by Application (2021-2032)
  • 6.3 Global Mesylate Safinamide Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Mesylate Safinamide Sales Quantity by Type (2021-2032)
  • 7.2 North America Mesylate Safinamide Sales Quantity by Application (2021-2032)
  • 7.3 North America Mesylate Safinamide Market Size by Country
    • 7.3.1 North America Mesylate Safinamide Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Mesylate Safinamide Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Mesylate Safinamide Sales Quantity by Type (2021-2032)
  • 8.2 Europe Mesylate Safinamide Sales Quantity by Application (2021-2032)
  • 8.3 Europe Mesylate Safinamide Market Size by Country
    • 8.3.1 Europe Mesylate Safinamide Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Mesylate Safinamide Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Mesylate Safinamide Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Mesylate Safinamide Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Mesylate Safinamide Market Size by Region
    • 9.3.1 Asia-Pacific Mesylate Safinamide Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Mesylate Safinamide Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Mesylate Safinamide Sales Quantity by Type (2021-2032)
  • 10.2 South America Mesylate Safinamide Sales Quantity by Application (2021-2032)
  • 10.3 South America Mesylate Safinamide Market Size by Country
    • 10.3.1 South America Mesylate Safinamide Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Mesylate Safinamide Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Mesylate Safinamide Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Mesylate Safinamide Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Mesylate Safinamide Market Size by Country
    • 11.3.1 Middle East & Africa Mesylate Safinamide Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Mesylate Safinamide Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Mesylate Safinamide Market Drivers
  • 12.2 Mesylate Safinamide Market Restraints
  • 12.3 Mesylate Safinamide Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Mesylate Safinamide and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Mesylate Safinamide
  • 13.3 Mesylate Safinamide Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Mesylate Safinamide Typical Distributors
  • 14.3 Mesylate Safinamide Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Mesylate Safinamide. Industry analysis & Market Report on Mesylate Safinamide is a syndicated market report, published as Global Mesylate Safinamide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Mesylate Safinamide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo